Published in Virulence on September 19, 2016
Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine Candidates. Front Immunol (2017) 0.79
The unmet clinical need of novel antifungal drugs. Virulence (2017) 0.75
Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity. Front Microbiol (2017) 0.75
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol (1998) 7.01
Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev (2007) 6.41
Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis (2007) 5.51
Coccidioidomycosis. Clin Infect Dis (2005) 3.88
Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia (2010) 3.81
Global control of dimorphism and virulence in fungi. Science (2006) 3.50
An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis (1969) 3.50
In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Antimicrob Agents Chemother (1996) 3.08
Coccidioidomycosis. N Engl J Med (1995) 3.01
Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med (1986) 2.87
Geographical distribution of histoplasmosis and histoplasmin sensitivity. Bull World Health Organ (1952) 2.68
Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis (2001) 2.51
In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species. Antimicrob Agents Chemother (1997) 2.51
Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis (2008) 2.35
Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis (2006) 2.02
Clinical and laboratory update on blastomycosis. Clin Microbiol Rev (2010) 2.01
Phylogenetic analysis reveals a high level of speciation in the Paracoccidioides genus. Mol Phylogenet Evol (2009) 1.99
Histoplasmosis. Clin Chest Med (2009) 1.91
Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol (2011) 1.84
Phylogenetic analysis reveals a cryptic species Blastomyces gilchristii, sp. nov. within the human pathogenic fungus Blastomyces dermatitidis. PLoS One (2013) 1.79
Irreversible block of the mycelial-to-yeast phase transition of Histoplasma capsulatum. Science (1986) 1.78
The habitat of Paracoccidioides brasiliensis: how far from solving the riddle? Med Mycol (2001) 1.75
Temperature-induced switch to the pathogenic yeast form of Histoplasma capsulatum requires Ryp1, a conserved transcriptional regulator. Proc Natl Acad Sci U S A (2008) 1.73
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother (2000) 1.59
In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob Agents Chemother (2003) 1.58
Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob Agents Chemother (2002) 1.57
A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA (1997) 1.54
Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrob Agents Chemother (1990) 1.54
Polyoxin D, a competitive inhibitor of UDP-N-acetylglucosamine: chitin N-acetylglucosaminyltransferase in Neurospora crassa. Biochem Biophys Res Commun (1969) 1.47
Expanding understanding of epidemiology of coccidioidomycosis in the Western hemisphere. Ann N Y Acad Sci (2007) 1.46
Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole. J Antimicrob Chemother (2006) 1.46
Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and to histoplasmin. Dis Chest (1957) 1.42
A temperature-responsive network links cell shape and virulence traits in a primary fungal pathogen. PLoS Biol (2013) 1.35
Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Respir Infect (1986) 1.27
A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med (1981) 1.24
Treatment of tropical mycoses. J Am Acad Dermatol (1994) 1.20
Design and optimization of highly-selective fungal CYP51 inhibitors. Bioorg Med Chem Lett (2014) 1.14
Point-source outbreak of coccidioidomycosis in construction workers. Epidemiol Infect (2009) 1.14
The incidence of hospitalized cases of systemic mycotic infections. Sabouraudia (1974) 1.13
Pulmonary coccidioidomycosis. Semin Respir Crit Care Med (2011) 1.12
Histoplasma capsulatum reactivation with haemophagocytic syndrome in a patient with chronic lymphocytic leukaemia. Neth J Med (2010) 1.11
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi. Med Mycol (2005) 1.11
Morphogenesis and pathogenicity of Histoplasma capsulatum. Infect Immun (1987) 1.11
Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model. Antimicrob Agents Chemother (2000) 1.10
Studies on polyoxins, antifungal antibiotics. 13. The structure of polyoxins. J Am Chem Soc (1969) 1.07
Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome. Clin Infect Dis (2001) 1.06
Histoplasmosis in Africa: a review. Indian J Chest Dis Allied Sci (2004) 1.05
Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas. Mycopathologia (2007) 1.02
Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother (2001) 1.02
Coccidioidomycosis outbreak among United States Navy SEALs training in a Coccidioides immitis-endemic area--Coalinga, California. J Infect Dis (2002) 1.01
Amphotericin B nephrotoxicity: increased renal resistance and tubule permeability. Kidney Int (1982) 1.01
Histoplasmosis: a new endemic fungal infection in China? Review and analysis of cases. Mycoses (2012) 1.01
Epidemiological investigation of Histoplasma capsulatum infection in China. Chin Med J (Engl) (2001) 0.99
Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis. J Infect Dis (2000) 0.98
Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent. Antimicrob Agents Chemother (2009) 0.98
Blastomycosis in indiana: digging up more cases. Chest (2010) 0.98
Role of cell-surface molecules of Blastomyces dermatitidis in host-pathogen interactions. Trends Microbiol (1996) 0.98
Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. Ann Clin Microbiol Antimicrob (2009) 0.97
Histoplasmosis complicating tumor necrosis factor-α blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis (2015) 0.96
Efficacy of nikkomycin Z in the treatment of murine histoplasmosis. Antimicrob Agents Chemother (1998) 0.95
Efficacy of nikkomycin Z against experimental pulmonary blastomycosis. Antimicrob Agents Chemother (1997) 0.95
EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS. Rev Inst Med Trop Sao Paulo (2015) 0.95
Reactivation of histoplasmosis after treatment with infliximab. Am J Med (2002) 0.94
Coccidioides posadasii contains a single 1,3-beta-glucan synthase gene that appears to be essential for growth. Eukaryot Cell (2005) 0.94
Identification, in vitro activity and mode of action of phosphoinositide-dependent-1 kinase inhibitors as antifungal molecules. ACS Chem Biol (2011) 0.94
Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses. Antiviral Res (2015) 0.94
Comparative genomics allowed the identification of drug targets against human fungal pathogens. BMC Genomics (2011) 0.93
Histoplasmosis. Infect Dis Clin North Am (2016) 0.93
Paracoccidioidomycosis. Clin Dermatol (2012) 0.92
Blastomycosis in Africa. A review of known cases diagnosed between 1951 and 1987. Mycopathologia (1989) 0.92
Coccidioidomycosis and histoplasmosis. A review of their epidemiology and geographical distribution. Mycopathol Mycol Appl (1971) 0.90
Occupational coccidioidomycosis in California: outbreak investigation, respirator recommendations, and surveillance findings. J Occup Environ Med (2012) 0.89
Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Infect Dis Clin North Am (2015) 0.88
Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area. Respir Med (2006) 0.88
The two-component histidine kinases DrkA and SlnA are required for in vivo growth in the human pathogen Penicillium marneffei. Mol Microbiol (2011) 0.88
Persistent pulmonary infection with an azole-resistant Coccidioides species. Med Mycol (2008) 0.87
Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models. Antimicrob Agents Chemother (2015) 0.86
Reactivation of coccidioidomycosis despite antifungal prophylaxis in solid organ transplant recipients. Transplantation (2011) 0.85
Coccidioidomycosis. Infect Dis Clin North Am (2015) 0.85
The Eng1 β-Glucanase Enhances Histoplasma Virulence by Reducing β-Glucan Exposure. MBio (2016) 0.85
Comparison between itraconazole and cotrimoxazole in the treatment of paracoccidiodomycosis. PLoS Negl Trop Dis (2014) 0.84
In vitro inhibitory effect of antituberculosis drugs on clinical and environmental strains of Coccidioides posadasii. J Antimicrob Chemother (2006) 0.84
Itraconazole vs. trimethoprim-sulfamethoxazole: A comparative cohort study of 200 patients with paracoccidioidomycosis. Med Mycol (2014) 0.83
Influence of different media, incubation times, and temperatures for determining the MICs of seven antifungal agents against Paracoccidioides brasiliensis by microdilution. J Clin Microbiol (2012) 0.83
Effect of farnesol on growth, ergosterol biosynthesis, and cell permeability in Coccidioides posadasii. Antimicrob Agents Chemother (2013) 0.83
Coccidioidomycosis: Recent Updates. Semin Respir Crit Care Med (2015) 0.82
A large histoplasmosis outbreak among high school students in Indiana, 2001. Pediatr Infect Dis J (2004) 0.82
In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum. Antimicrob Agents Chemother (2010) 0.82
Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors. J Enzyme Inhib Med Chem (2013) 0.82
Histoplasmosis: Up-to-Date Evidence-Based Approach to Diagnosis and Management. Semin Respir Crit Care Med (2015) 0.81
Comparison of nikkomycin Z with amphotericin B and itraconazole for treatment of histoplasmosis in a murine model. Antimicrob Agents Chemother (2000) 0.81
Blastomycosis. Infect Dis Clin North Am (2015) 0.80
Identification of an aminothiazole with antifungal activity against intracellular Histoplasma capsulatum. Antimicrob Agents Chemother (2013) 0.80
Histoplasmosis infections worldwide: thinking outside of the Ohio River valley. Curr Trop Med Rep (2015) 0.80
In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from Northeast, Brazil. Mycopathologia (2006) 0.80
Investigation of the efficacy of micafungin in the treatment of histoplasmosis using two North American strains of Histoplasma capsulatum. Antimicrob Agents Chemother (2011) 0.80
Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii. Mycoses (2012) 0.80
Valley fever: danger lurking in a dust cloud. Microbes Infect (2014) 0.80
Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum. Antimicrob Agents Chemother (2014) 0.79
Quantitative Microplate-Based Growth Assay for Determination of Antifungal Susceptibility of Histoplasma capsulatum Yeasts. J Clin Microbiol (2015) 0.79